Home Tagworks Pharmaceuticals

Tagworks Pharmaceuticals

In operation
Series A
Biotechnology Researcher

Basic Information

Tagworks Pharmaceuticals aims to address the challenges of introducing antibody-drug conjugates (ADCs) and other effective therapies into mainstream cancer treatment. We are pioneers in what is known as click-to-release technology and the first company to utilize this therapeutic approach.
Tagworks Pharmaceuticals B.V.
Nijmegen,Gelderland,Netherlands
less than 15 people
January 01, 2011
info@tagworkspharma.com